Despite advances in point of care, mid- to large-volume IVD instruments remain cost-effective and highly reliable choices for labs. Although they are complex and expensive to develop, these instruments answer a global need and retain several advantages over their smaller, more-portable counterparts.

by: Interview by Richard Park

Hematology instrumentation developers must be equipped to meet technology challenges coupled with IVD manufacturers’ demands for speed-to-market and cost efficiency.

by: Henri Champseix and Eric Jolain

The editors of IVD Technology asked industry analysts to share their thoughts and opinions on next year’s elections, the IVD-related issues that could be raised during the election year, and their potential impact on the IVD industry and IVD manufacturers.

Sony bought Micronics to boost its own R&D in the area of point-of-care diagnostic equipment and to accelerate commercialization of these products.

by: Maureen Kingsley

by: Richard Park